| The spliceosome is a therapeutic vulnerability in MYC-driven cancer TYT Hsu, LM Simon, NJ Neill, R Marcotte, A Sayad, CS Bland, ... Nature 525 (7569), 384-388, 2015 | 460 | 2015 |
| Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state GV Echeverria, Z Ge, S Seth, X Zhang, S Jeter-Jones, X Zhou, S Cai, Y Tu, ... Science translational medicine 11 (488), eaav0936, 2019 | 236 | 2019 |
| High-resolution clonal mapping of multi-organ metastasis in triple negative breast cancer GV Echeverria, E Powell, S Seth, Z Ge, A Carugo, C Bristow, M Peoples, ... Nature communications 9 (1), 5079, 2018 | 108 | 2018 |
| RNA-binding proteins in microsatellite expansion disorders: mediators of RNA toxicity GV Echeverria, TA Cooper Brain research 1462, 100-111, 2012 | 96 | 2012 |
| Identification of MBNL1 and MBNL3 domains required for splicing activation and repression I Grammatikakis, YH Goo, GV Echeverria, TA Cooper Nucleic acids research 39 (7), 2769-2780, 2011 | 66 | 2011 |
| Phosphorylation of serine 367 of FOXC2 by p38 regulates ZEB1 and breast cancer metastasis, without impacting primary tumor growth SJ Werden, N Sphyris, TR Sarkar, AN Paranjape, AM LaBaff, JH Taube, ... Oncogene 35 (46), 5977-5988, 2016 | 60 | 2016 |
| p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived … E Powell, J Shao, Y Yuan, HC Chen, S Cai, GV Echeverria, N Mistry, ... Breast Cancer Research 18, 1-16, 2016 | 50 | 2016 |
| Muscleblind-like 1 activates insulin receptor exon 11 inclusion by enhancing U2AF65 binding and splicing of the upstream intron GV Echeverria, TA Cooper Nucleic acids research 42 (3), 1893-1903, 2014 | 48 | 2014 |
| Proteogenomic markers of chemotherapy resistance and response in triple-negative breast cancer M Anurag, EJ Jaehnig, K Krug, JT Lei, EJ Bergstrom, BJ Kim, TD Vashist, ... Cancer discovery 12 (11), 2586-2605, 2022 | 37 | 2022 |
| Laboratory models for investigating breast cancer therapy resistance and metastasis K Roarty, GV Echeverria Frontiers in oncology 11, 645698, 2021 | 34 | 2021 |
| Subclonal heterogeneity and evolution in breast cancer I Mavrommati, F Johnson, GV Echeverria, R Natrajan NPJ Breast Cancer 7 (1), 155, 2021 | 27 | 2021 |
| Mitochondrial structure and function adaptation in residual triple negative breast cancer cells surviving chemotherapy treatment ML Baek, J Lee, KE Pendleton, MJ Berner, EB Goff, L Tan, SA Martinez, ... Oncogene 42 (14), 1117-1131, 2023 | 16 | 2023 |
| Pharmacologic profiling of patient-derived xenograft models of primary treatment-naïve triple-negative breast cancer RT Powell, A Redwood, X Liu, L Guo, S Cai, X Zhou, Y Tu, X Zhang, Y Qi, ... Scientific reports 10 (1), 17899, 2020 | 12 | 2020 |
| Methodological Advancements for Investigating Intra-tumoral Heterogeneity in Breast Cancer at the Bench and Bedside M Baek, JT Chang, E Gloria V Journal of Mammary Gland Biology and Neoplasia, 2020 | 7 | 2020 |
| Predictors of success in establishing orthotopic patient-derived xenograft models of triple negative breast cancer GV Echeverria, S Cai, Y Tu, J Shao, E Powell, AB Redwood, Y Jiang, ... NPJ Breast Cancer 9 (1), 2, 2023 | 5 | 2023 |
| Rewiring of mitochondrial metabolism in therapy-resistant cancers: permanent and plastic adaptations KE Pendleton, K Wang, GV Echeverria Frontiers in Cell and Developmental Biology 11, 2023 | 5 | 2023 |
| Evolution of cisplatin resistance through coordinated metabolic reprogramming of the cellular reductive state W Yu, Y Chen, N Putluri, A Osman, C Coarfa, V Putluri, AHM Kamal, ... British journal of cancer 128 (11), 2013-2024, 2023 | 3 | 2023 |
| Improving the odds together: a framework for breast cancer research scientists to include patient advocates in their research H Stires, I Bado, T Brown, M Carlson, IS Chan, GV Echeverria, AJ Ewald, ... npj Breast Cancer 8 (1), 75, 2022 | 1 | 2022 |
| Analysis of spatiotemporal phenotypic heterogeneity in chemoresistant triple negative breast cancer using imaging mass cytometry AL Rinkenbaugh, VC Sinha, GV Echeverria, X Zhang, J Shao, ... Cancer Research 80 (16_Supplement), 1513-1513, 2020 | 1 | 2020 |
| Abstract PO2-28-08: A spatial transcriptomic study of a triple-negative breast cancer (TNBC) patient-derived xenograft (PDX) model of residual disease refractory to … B Strope, K Pendleton, W Bowie, G Echeverria, Q Zhu Cancer Research 84 (9_Supplement), PO2-28-08-PO2-28-08, 2024 | | 2024 |
